Isolated limb perfusion in primary and recurrent melanoma: Indications and results
Danielle Líénard(University Hospital of Lausanne), Ferdinand Lejeune, Heimen Schraffordt Koops, Alexander M.M. Eggermont(University Medical Center Utrecht), Bin B. R. Kroon
Seminars in Surgical Oncology
April 1, 1998
Cited by 68
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k